The opposing roles of NOTCH signalling in head and neck cancer: A mini review

Oral Diseases

Volumn 21, Issue 7, 2015, Pages 850-857

  Yap, L F ^a   Lee, D ^a   Khairuddin, A N M ^a   Pairan, M F ^a   Puspita, B ^a   Siar, C H ^a   Paterson, I C ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

NOTCH; Head and neck cancer; Mutations; Oncogene; Tumour suppressor

Indexed keywords

NOTCH RECEPTOR; TUMOR SUPPRESSOR PROTEIN;

CELL HETEROGENEITY; HEAD AND NECK CANCER; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; NONHUMAN; NOTCH SIGNALLING; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; GENETICS; HEAD AND NECK TUMOR; METABOLISM; MUTATION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ANIMALS; CARCINOMA, SQUAMOUS CELL; GENES, TUMOR SUPPRESSOR; HEAD AND NECK NEOPLASMS; HUMANS; MUTATION; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

EID: 84941620711     PISSN: 1354523X     EISSN: 16010825     Source Type: Journal    
DOI: 10.1111/odi.12309     Document Type: Review

References (58)

1. Agrawal N, Frederick MJ, Pickering CR et al (2011). Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333: 1154-1157.
2. Bailey AM, Posakony JW (1995). Suppressor of hairless directly activates transcription of enhancer of split complex genes in response to Notch receptor activity. Genes Dev 9: 2609-2622.
3. Baldus CD, Thibaut J, Goekbuget N et al (2009). Prognostic implications of NOTCH1 and FBXW7 mutations in adult acute T-lymphoblastic leukemia. Haematologica 94: 1383-1390.
4. Bray SJ (2006). Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol 7: 678-689.
5. Capaccione KM, Pine SR (2013). The Notch signaling pathway as a mediator of tumor survival. Carcinogenesis 34: 1420-1430.
6. Cui H, Kong Y, Xu M et al (2013). Notch3 functions as a tumor suppressor by controlling cellular senescence. Cancer Res 73: 3451-3459.
7. Demehri S, Turkoz A, Kopan R (2009). Epidermal Notch1 loss promotes skin tumorigenesis by impacting the stromal microenvironment. Cancer Cell 16: 55-66.
8. Devgan V, Mammucari C, Millar SE et al (2005). p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation. Genes Dev 19: 1485-1495.
9. D'Souza B, Miyamoto A, Weinmaster G (2008). The many facets of Notch ligands. Oncogene 27: 5148-5167.
10. Duan L, Yao J, Wu X et al (2006). Growth suppression induced by Notch1 activation involves Wnt-beta-catenin down-regulation in human tongue carcinoma cells. Biol Cell 98: 479-490.
11. Ellisen LW, Bird J, West DC et al (1991). TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell 66: 649-661.
12. Espinoza I, Pochampally R, Xing F et al (2013). Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition. Onco Targets Ther 6: 1249-1259.
13. Gallahan D, Callahan R (1997). The mouse mammary tumor associated gene INT3 is a unique member of the NOTCH gene family (NOTCH4). Oncogene 14: 1883-1890.
14. Gallahan D, Kozak C, Callahan R (1987). A new common integration region (int-3) for mouse mammary tumor virus on mouse chromosome 17. J Virol 61: 218-220.
15. Gokulan R, Halagowder D (2014). Expression pattern of Notch intracellular domain (NICD) and Hes-1 in preneoplastic and neoplastic human oral squamous epithelium: their correlation with c-Myc, clinicopathological factors and prognosis in oral cancer. Med Oncol 31: 126.
16. Gordon WR, Arnett KL, Blacklow SC (2008). The molecular logic of Notch signaling-a structural and biochemical perspective. J Cell Sci 121: 3109-3119.
17. Gu F, Ma Y, Zhang Z et al (2010). Expression of Stat3 and Notch1 is associated with cisplatin resistance in head and neck squamous cell carcinoma. Oncol Rep 23: 671-676.
18. Hijioka H, Setoguchi T, Miyawaki A et al (2010). Upregulation of Notch pathway molecules in oral squamous cell carcinoma. Int J Oncol 36: 817-822.
19. Hunter KD, Thurlow JK, Fleming J et al (2006). Divergent routes to oral cancer. Cancer Res 66: 7405-7413.
20. Jarriault S, Le Bail O, Hirsinger E et al (1998). Delta-1 activation of notch-1 signaling results in HES-1 transactivation. Mol Cell Biol 18: 7423-7431.
21. Joo YH, Jung CK, Kim MS et al (2009). Relationship between vascular endothelial growth factor and Notch1 expression and lymphatic metastasis in tongue cancer. Otolaryngol Head Neck Surg 140: 512-518.
22. Kagawa S, Natsuizaka M, Whelan KA et al (2014). Cellular senescence checkpoint function determines differential Notch1-dependent oncogenic and tumor-suppressor activities. Oncogene doi: 10.1038/onc.2014.169. [Epub ahead of print].
23. Kamangar F, Dores GM, Anderson WF (2006). Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24: 2137-2150.
24. Kandoth C, McLellan MD, Vandin F et al (2013). Mutational landscape and significance across 12 major cancer types. Nature 502: 333-339.
25. Kao HY, Ordentlich P, Koyano-Nakagawa N et al (1998). A histone deacetylase corepressor complex regulates the Notch signal transduction pathway. Genes Dev 12: 2269-2277.
26. Klinakis A, Lobry C, Abdel-Wahab O et al (2011). A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia. Nature 473: 230-233.
27. Kovall RA (2008). More complicated than it looks: assembly of Notch pathway transcription complexes. Oncogene 27: 5099-5109.
28. Lee SH, Hong HS, Liu ZX et al (2012). TNFalpha enhances cancer stem cell-like phenotype via Notch-Hes1 activation in oral squamous cell carcinoma cells. Biochem Biophys Res Commun 424: 58-64.
29. Leemans CR, Braakhuis BJ, Brakenhoff RH (2011). The molecular biology of head and neck cancer. Nat Rev Cancer 11: 9-22.
30. Leethanakul C, Patel V, Gillespie J et al (2000). Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays. Oncogene 19: 3220-3224.
31. McGill MA, McGlade CJ (2003). Mammalian numb proteins promote Notch1 receptor ubiquitination and degradation of the Notch1 intracellular domain. J Biol Chem 278: 23196-23203.
32. Nickoloff BJ, Qin JZ, Chaturvedi V et al (2002). Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-kappaB and PPARgamma. Cell Death Differ 9: 842-855.
33. Nicolas M, Wolfer A, Raj K et al (2003). Notch1 functions as a tumor suppressor in mouse skin. Nat Genet 33: 416-421.
34. Palomero T, Lim WK, Odom DT et al (2006). NOTCH1 directly regulates c-MYC and activates a feed-forward-loop transcriptional network promoting leukemic cell growth. Proc Natl Acad Sci USA 103: 18261-18266.
35. Pickering CR, Zhang J, Yoo SY et al (2013). Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discov 3: 770-781.
36. Pickering CR, Zhou JH, Lee JJ et al (2014). Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clin Cancer Res 20: 6582-6592.
37. Qi R, An H, Yu Y et al (2003). Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. Cancer Res 63: 8323-8329.
38. Rampal R, Arboleda-Velasquez JF, Nita-Lazar A et al (2005). Highly conserved O-fucose sites have distinct effects on Notch1 function. J Biol Chem 280: 32133-32140.
39. Ranganathan P, Weaver KL, Capobianco AJ (2011). Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer 11: 338-351.
40. Rangarajan A, Talora C, Okuyama R et al (2001). Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation. EMBO J 20: 3427-3436.
41. Reedijk M, Odorcic S, Chang L et al (2005). High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Res 65: 8530-8537.
42. Ronchini C, Capobianco AJ (2001). Induction of cyclin D1 transcription and CDK2 activity by Notch(ic): implication for cell cycle disruption in transformation by Notch(ic). Mol Cell Biol 21: 5925-5934.
43. Sakamoto K, Fujii T, Kawachi H et al (2012). Reduction of NOTCH1 expression pertains to maturation abnormalities of keratinocytes in squamous neoplasms. Lab Invest 92: 688-702.
44. Song X, Xia R, Li J et al (2014). Common and complex Notch1 mutations in Chinese oral squamous cell carcinoma. Clin Cancer Res 20: 701-710.
45. South AP, Purdie KJ, Watt SA et al (2014). NOTCH1 mutations occur early during cutaneous squamous cell carcinogenesis. J Invest Dermatol 134: 2630-2638.
46. Sriuranpong V, Borges MW, Ravi RK et al (2001). Notch signaling induces cell cycle arrest in small cell lung cancer cells. Cancer Res 61: 3200-3205.
47. Stransky N, Egloff AM, Tward AD et al (2011). The mutational landscape of head and neck squamous cell carcinoma. Science 333: 1157-1160.
48. Sun W, Gaykalova DA, Ochs MF et al (2014). Activation of the NOTCH pathway in head and neck cancer. Cancer Res 74: 1091-1104.
49. Vilimas T, Mascarenhas J, Palomero T et al (2007). Targeting the NF-kappaB signaling pathway in Notch1-induced T-cell leukemia. Nat Med 13: 70-77.
50. Wang Z, Li Y, Ahmad A et al (2010). Targeting Notch signaling pathway to overcome drug resistance for cancer therapy. Biochim Biophys Acta 1806: 258-267.
51. Wang NJ, Sanborn Z, Arnett KL et al (2011). Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. Proc Natl Acad Sci USA 108: 17761-17766.
52. Weng AP, Ferrando AA, Lee W et al (2004). Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306: 269-271.
53. Wu G, Lyapina S, Das I et al (2001). SEL-10 is an inhibitor of notch signaling that targets notch for ubiquitin-mediated protein degradation. Mol Cell Biol 21: 7403-7415.
54. Yao J, Duan L, Fan M et al (2007). Gamma-secretase inhibitors exerts antitumor activity via down-regulation of Notch and Nuclear factor kappa B in human tongue carcinoma cells. Oral Dis 13: 555-563.
55. Yoshida R, Nagata M, Nakayama H et al (2013). The pathological significance of Notch1 in oral squamous cell carcinoma. Lab Invest 93: 1068-1081.
56. Zeng Q, Li S, Chepeha DB et al (2005). Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. Cancer Cell 8: 13-23.
57. Zhang TH, Liu HC, Zhu LJ et al (2011). Activation of Notch signaling in human tongue carcinoma. J Oral Pathol Med 40: 37-45.
58. Zhu AJ, Watt FM (1999). Beta-catenin signalling modulates proliferative potential of human epidermal keratinocytes independently of intercellular adhesion. Development 126: 2285-2298.